The calcimimetic etelcalcetide attenuates pressure overload-induced cardiac hypertrophy in rats with and without chronic kidney disease
Biomed Pharmacother. 2026 Jan 30;196:119054. doi: 10.1016/j.biopha.2026.119054. Online ahead of print.ABSTRACTINTRODUCTION: Calcimimetics such as etelcalcetide (ET) are used to manage secondary hyperparathyroidism patients with chronic kidney disease (CKD) on dialysis. While their cardiovascular ben

